• Lisata Therapeutics extended the deadline to complete its merger with Kuva Labs to July 21, 2026 from July 17, 2026.
• The amendment was agreed with Kuva Labs and its merger subsidiary, Kuva Acquisition.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lisata Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001140361-26-028763), on July 17, 2026, and is solely responsible for the information contained therein.